Australian drug regulator gives company green light for tablet – although it won’t be subsidised by Pharmaceutical Benefits Scheme
The first new endometriosis treatment in 13 years – aimed at relieving the debilitating pain many with the condition suffer – has been approved by Australia’s drug regulator.
Endometriosis is a chronic condition that occurs when tissue similar to the lining of the uterus grows outside it, affecting other organs and leading to inflammation, lesions and scar tissue.
Continue reading...